Dr. Jordan Leigh Jamerson, MD

Dr. Jamerson practices at Shannon Medical Center in San Angelo, Texas, part of Shannon Health System.

Dr. Jamerson's NPI, 1285012153, was assigned on May 12, 2015. Dr. Jamerson graduated from Texas Tech University Health Sciences Center School of Medicine in 2015. Dr. Jamerson holds Texas license S1421.

Dr. Jamerson's primary practice is Shannon Medical Center, at 120 E Harris Ave., San Angelo, TX 76903 in Tom Green County. The practice phone is (325) 653-6741.

Dr. Jamerson's primary practice is Shannon Medical Center in San Angelo, Texas, part of Shannon Health System. The medical group on file is Shannon Clinic. Dmand AI also links Dr. Jamerson to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Jamerson practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Jamerson's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Jamerson is board certified in dermatology by the American Board of Dermatology. Dr. Jamerson is licensed in Texas.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, itchy rashes and psoriasis among the conditions Dr. Jamerson treats.

CMS data shows 1,963 Medicare services from Dr. Jamerson across 14 procedure codes in 2024, for 389 Medicare patients. Medicare paid $80,409 for them. Every service was in an office.

CMS counts 389 Medicare patients who saw Dr. Jamerson in 2024. The largest group is 65 to 74, with 191 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.08, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Jamerson's median patient age at 73, with 64% women.

In 2024, Dr. Jamerson wrote 636 Medicare Part D claims for 277 patients. 97% of them were for generic drugs. CMS names the drug for 515 of them, across 10 drugs with 11 or more claims each, at $10,204 in total drug cost. In 2023, CMS named 337 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Jamerson for performance year 2024, reported as part of a group. Dr. Jamerson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 530 procedures of removal of skin lesions by Dr. Jamerson, more than 87% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 5 papers to Dr. Jamerson, published from 2018 to 2021. The most frequent topics are Skin Neoplasms. Dr. Jamerson's most frequent co-authors are Amy Rocky Brackeen, MD, Jeffrey Scott Brackeen, MD and Chad D. Housewright, MD.

CMS Open Payments shows 76 general payments to Dr. Jamerson from 21 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 83% of the total. Abbvie Inc. paid the most, $606.

Dmand AI lists 1 award for Dr. Jamerson.

Dr. Jamerson graduated from Texas Tech University Health Sciences Center School of Medicine in 2015.

Dr. Jamerson is in network with 22 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.